.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Healthtrust
Johnson and Johnson
Chinese Patent Office
Cerilliant
Citi
Boehringer Ingelheim
US Army
Farmers Insurance
US Department of Justice

Generated: July 22, 2017

DrugPatentWatch Database Preview

Iodoxamate meglumine - Generic Drug Details

« Back to Dashboard

What are the generic sources for iodoxamate meglumine and what is the scope of iodoxamate meglumine freedom to operate?

Iodoxamate meglumine
is the generic ingredient in one branded drug marketed by Bracco and is included in two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Summary for Generic Name: iodoxamate meglumine

Tradenames:1
Patents:1
Applicants:1
NDAs:2
Bulk Api Vendors: see list10
Clinical Trials: see list31
Patent Applications: see list22
Drug Prices:see low prices
DailyMed Link:iodoxamate meglumine at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco
CHOLOVUE
iodoxamate meglumine
INJECTABLE;INJECTION018077-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Bracco
CHOLOVUE
iodoxamate meglumine
INJECTABLE;INJECTION018076-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: iodoxamate meglumine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bracco
CHOLOVUE
iodoxamate meglumine
INJECTABLE;INJECTION018076-001Approved Prior to Jan 1, 19823,654,272► Subscribe
Bracco
CHOLOVUE
iodoxamate meglumine
INJECTABLE;INJECTION018077-001Approved Prior to Jan 1, 19823,654,272► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Argus Health
Merck
Fish and Richardson
Novartis
Deloitte
McKesson
Chubb
Boehringer Ingelheim
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot